TARGETED THERAPY FOR FLUOROQUINOLONES IN INFANTS AND CHILDREN

2/25/02


Click here to start


Table of Contents

TARGETED THERAPY FOR FLUOROQUINOLONES IN INFANTS AND CHILDREN

WHY FQ THERAPY FOR MENINGITIS

ANTIBIOTIC THERAPY IN EXPERIMENTAL MENINGITIS: RELEVANT PRINCIPLES

DETERMINING ANTIBIOTIC REGIMEN IN HUMANS FROM EXPERIMENTAL MENINGITIS MODEL

PPT Slide

TROVAFLOXACIN STUDY DEMOGRAPHICS*

CLINICAL AND MICROBIOLOGIC OUTCOMES OF EVALUABLE PATIENTS*

CLINICAL OUTCOME: ITT ANALYSIS

TROVAFLOXACIN STUDY: ADVERSE EVENTS (ITT)*

RESTRICTIONS ON PERFORMING STUDIES OF ANTIBIOTIC THERAPY FOR MENINGITIS

REQUISITES TO CONDUCTING INTERNATIONAL STUDIES

ANALYSIS OF EQUIVALENCE OR NON-INFERIORITY

EQUIVALENCE OF THERAPEUTIC AGENTS

SAMPLE SIZE ESTIMATIONS (using ? = .05 AND = .20)

EQUIVALENCE IN RANDOMIZED CONTROLLED TRIALS OF THERAPY FOR BACTERIAL MENINGITIS*

POTENTIAL PROBLEMS WITH ENROLLING MENINGITIS PATIENTS FROM DEVELOPING COUNTRIES

ROLE OF ANTIBIOTICS FOR MENINGITIS THERAPY

BACTERIOLOGIC SUCCESS OF TROVAFLOXACIN VS CEFTRIAXONE IN BACTERIAL MENINGITIS

DELAYED CSF STERILIZATION AND OUTCOME IN BACTERIAL MENINGITIS*

CRITICAL ENDPOINTS FOR ASSESSING EFFECTIVENESS OF ABX FOR MENINGITIS

Author: Sherrie Myers